Anti-C1q in chronic hepatitis C virus genotype IV infection: association with autoimmune rheumatologic manifestations.

about

The Complement System and C1q in Chronic Hepatitis C Virus Infection and Mixed Cryoglobulinemia.Interleukin-17A and B-cell activating factor in chronic hepatitis C patients with or without asymptomatic mixed cryoglobulinemia: effects of antiviral treatment and correlations with vitamin D

P2860

Q55130392-21BEBCAA-8841-4788-B558-A27D57B8E3AB Q58541796-B1573390-C488-491A-9B7F-813C8F06645D

P2860

Anti-C1q in chronic hepatitis C virus genotype IV infection: association with autoimmune rheumatologic manifestations.

Item

http://www.wikidata.org/entity/Q42206002

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Anti-C1q in chronic hepatitis ...... rheumatologic manifestations.

@en

Anti-C1q in chronic hepatitis ...... rheumatologic manifestations.

@nl

type

Item

label

Anti-C1q in chronic hepatitis ...... rheumatologic manifestations.

@en

Anti-C1q in chronic hepatitis ...... rheumatologic manifestations.

@nl

prefLabel

Anti-C1q in chronic hepatitis ...... rheumatologic manifestations.

@en

Anti-C1q in chronic hepatitis ...... rheumatologic manifestations.

@nl

P1476

Anti-C1q in chronic hepatitis ...... e rheumatologic manifestations

@en

P2093

Ahmed Hamdy

http://www.w3.org/2001/XMLSchema#string

Iman E Wali

http://www.w3.org/2001/XMLSchema#string

Nermeen A Foad

http://www.w3.org/2001/XMLSchema#string

Samia H Fadda

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-C1q antibodies in hepatitis C virus infection

Complement: a key system for immune surveillance and homeostasis

Molecular signature in HCV-positive lymphomas

Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection.

Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications.

Hepatitis C virus: from entry to renal injury--facts and potentials.

Hepatitis C and autoreactivity.

Complement component c1q and anti-c1q antibodies in theory and in clinical practice.

Anti-C1q autoantibodies.

BAFF-targeting therapy, a promising strategy for treating autoimmune diseases.

P304

45-55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/08820139.2014.932378

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Iman H. Bassyouni

P577

2014-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25028787

http://www.w3.org/2001/XMLSchema#string

Anti-C1q in chronic hepatitis C virus genotype IV infection: association with autoimmune rheumatologic manifestations.

about

P2860

P2860

Anti-C1q in chronic hepatitis C virus genotype IV infection: association with autoimmune rheumatologic manifestations.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698